Shikonin stimulates MC3T3-E1 cell proliferation and differentiation via the BMP-2/Smad5 signal transduction pathway

Fang,Tao; Wu,Qianqian; Mu,Shuai; Yang,Liyu; Liu,Shengye; Fu,Qin

doi:10.3892/mmr.2016.5363

Shikonin stimulates MC3T3-E1 cell proliferation and differentiation via the BMP-2/Smad5 signal transduction pathway

Authors:
- Tao Fang
- Qianqian Wu
- Shuai Mu
- Liyu Yang
- Shengye Liu
- Qin Fu
View Affiliations

Affiliations: Department of Orthopedic Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110000, P.R. China, Department of Cardiology, First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110000, P.R. China
Published online on: June 3, 2016 https://doi.org/10.3892/mmr.2016.5363
Pages: 1269-1274

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Shikonin, the predominant naphthoquinone pigment isolated from the Chinese plant Lithospermum erythrorhizon, is anti‑inflammatory, antiviral and exerts anticancer effects, amongst other biological activities. However, it is unknown whether shikonin affects bone formation. In the present study, the role of shikonin on cell proliferation was assessed via MTT assay, and shikonin was identified to markedly promote cell growth in a time‑ and dose‑dependent manner in the MC3T3‑E1 cell line. In addition, flow cytometric analysis was performed to evaluate the effect of shikonin on the cell cycle, and it was observed that shikonin markedly increased the percentage of S‑phase MC3T3‑E1 cells to accelerate the G1/S transition. To investigate the potential molecular mechanism by which shikonin enhances bone formation, the changes in bone morphogenic protein‑2 (BMP‑2), SMAD family member 5 (Smad5), runt related transcription factor 2 (Runx2), alkaline phosphatase (ALP) and osteocalcin (OC) expression levels induced by shikonin were investigated using western blot analysis and quantitative polymerase chain reaction. The results indicated that shikonin increased the BMP‑2 and Smad5 mRNA levels, and upregulated Smad5 and Runx2 protein expression levels to promote osteoblast differentiation. Furthermore, ALP staining was performed, and revealed that shikonin enhanced ALP activity. These results indicate that shikonin promotes cell proliferation and differentiation of MC3T3-E1 cells via the BMP-2/Smad5 signaling pathway.

View Figures

View References

1	Bone H: Future directions in osteoporosis therapeutics. Endocrinol Metab Clin North Am. 41:655–661. 2012. View Article : Google Scholar : PubMed/NCBI
2	Sharma L, Kapoor D and Issa S: Epidemiology of osteoarthritis: An update. Curr Opin Rheumatol. 18:147–156. 2006. View Article : Google Scholar : PubMed/NCBI
3	Lane NE: Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol. 194(2 Suppl): S3–S11. 2006. View Article : Google Scholar : PubMed/NCBI
4	Kobayashi Y, Uehara S, Koide M and Takahashi N: The regulation of osteoclast differentiation by Wnt signals. Bonekey Rep. 4:7132015. View Article : Google Scholar : PubMed/NCBI
5	Zhou H, Wang S, Xue Y and Shi N: Regulation of the levels of Smad1 and Smad5 in MC3T3-E1 cells by Icariine in vitro. Mol Med Rep. 9:590–594. 2014.
6	Andújar I, Rios JL, Giner RM and Recio MC: Pharmacological properties of shikonin-a review of literature since 2002. Planta Med. 79:1685–1697. 2013. View Article : Google Scholar
7	Chen X, Yang L, Oppenheim JJ and Howard MZ: Cellular pharmacology studies of shikonin derivatives. Phytother Res. 16:199–209. 2002. View Article : Google Scholar : PubMed/NCBI
8	Wang Y, Zhou Y, Jia G, Han B, Liu J, Teng Y, Lv J, Song Z, Li Y, Ji L, et al: Shikonin suppresses tumor growth and synergizes with gemcitabine in a pancreatic cancer xenograft model: Involvement of NF-kB signaling pathway. Biochem Pharmacol. 88:322–333. 2014. View Article : Google Scholar : PubMed/NCBI
9	Han W, Li L, Qiu S, Lu Q, Pan Q, Gu Y, Luo J and Hu X: Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Mol Cancer Ther. 6:1641–1649. 2007. View Article : Google Scholar : PubMed/NCBI
10	Chang IC, Huang YJ, Chiang TI, Yeh CW and Hsu LS: Shikonin induces apoptosis through reactive oxygen species/extracellular signal-regulated kinase pathway in osteosarcoma cells. Biol Pharm Bull. 33:816–824. 2010. View Article : Google Scholar : PubMed/NCBI
11	Knoll BI, McCarthy TL, Centrella M and Shin J: Strain-dependent control of transforming growth factor-beta function in osteoblasts in an in vitro model: Biochemical events associated with distraction osteogenesis. Plast Reconstr Surg. 116:224–233. 2005. View Article : Google Scholar : PubMed/NCBI
12	Fagenholz PJ, Warren SM, Greenwald JA, Bouletreau PJ, Spector JA, Crisera FE and Longaker MT: Osteoblast gene expression is differentially regulated by TGF-beta isoforms. J Craniofac Surg. 12:183–190. 2001. View Article : Google Scholar : PubMed/NCBI
13	Cao H, Ke Y, Zhang Y, Zhang CJ, Qian W and Zhang GL: Icariin stimulates MC3T3-E1 cell proliferation and differentiation through up-regulation of bone morphogenetic protein-2. Int J Mol Med. 29:435–439. 2012.
14	Liang W, Lin M, Li X, Li C, Gao B, Gan H, Yang Z, Lin X, Liao L and Yang M: Icariin promotes bone formation via the BMP-2/Smad4 signal transduction pathway in the hFOB 1.19 human osteoblastic cell line. Int J Mol Med. 30:889–895. 2012.PubMed/NCBI
15	Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Luu HH, An N, Breyer B, Vanichakarn P, et al: Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am. 85-A:1544–1552. 2003.PubMed/NCBI
16	Ghosh-Choudhury N, Singha PK, Woodruff K, St Clair P, Bsoul S, Werner SL and Choudhury GG: Concerted action of Smad and CREB-binding protein regulates bone morphogenetic protein-2-stimulated osteoblastic colony-stimulating factor-1 expression. J Biol Chem. 281:20160–20170. 2006. View Article : Google Scholar : PubMed/NCBI
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
18	Hiligsmann M, Vanoverberghe M, Neuprez A, Bruyère O and Reginster JY: Cost-effectiveness of strontium ranelate for the prevention and treatment of osteoporosis. Expert Rev Pharmacoecon Outcomes Res. 10:359–366. 2010. View Article : Google Scholar : PubMed/NCBI
19	Compston J: Osteoporosis: Social and economic impact. Radiol Clin North Am. 48:477–482. 2010. View Article : Google Scholar : PubMed/NCBI
20	Swarnkar G, Sharan K, Siddiqui JA, Chakravarti B, Rawat P, Kumar M, Arya KR, Maurya R and Chattopadhyay N: A novel flavonoid isolated from the steam-bark of Ulmus Wallichiana Planchon stimulates osteoblast function and inhibits osteoclast and adipocyte differentiation. Eur J Pharmacol. 658:65–73. 2011. View Article : Google Scholar : PubMed/NCBI
21	Tabuchi M, Miyazawa K, Kimura M, Maeda H, Kawai T, Kameyama Y and Goto S: Enhancement of crude bone morphogenetic protein-induced new bone formation and normalization of endochondral ossification by bisphosphonate treatment in osteoprotegerin-deficient mice. Calcif Tissue Int. 77:239–249. 2005. View Article : Google Scholar : PubMed/NCBI
22	Chen X, Yang L, Zhang N, Turpin JA, Buckheit RW, Osterling C, Oppenheim JJ and Howard OM: Shikonin, a component of Chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1. Antimicrob Agents Chemother. 47:2810–2816. 2003. View Article : Google Scholar : PubMed/NCBI
23	Yeh CC, Kuo HM, Li TM, Lin JP, Yu FS, Lu HF, Chung JG and Yang JS: Shikonin-induced apoptosis involves caspase-3 activity in a human bladder cancer cell line (T24). In Vivo. 21:1011–1019. 2007.
24	Wiench B, Eichhorn T, Paulsen M and Efferth T: Shikonin directly targets mitochondria and causes mitochondrial dysfunction in cancer cells. Evid Based Complement Alternat Med. 2012:7260252012. View Article : Google Scholar : PubMed/NCBI
25	Kamiya N, Ye L, Kobayashi T, Mochida Y, Yamauchi M, Kronenberg HM, Feng JQ and Mishina Y: BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. Development. 135:3801–3811. 2008. View Article : Google Scholar : PubMed/NCBI
26	Yoshida Y, Tanaka S, Umemori H, Minowa O, Usui M, Ikematsu N, Hosoda E, Imamura T, Kuno J, Yamashita T, et al: Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell. 103:1085–1097. 2000. View Article : Google Scholar
27	Harada S and Rodan GA: Control of osteoblast function and regulation of bone mass. Nature. 423:349–355. 2003. View Article : Google Scholar : PubMed/NCBI
28	Wang L, Zhang X, Guo Y, Chen X, Li R, Liu L, Shi C, Guo C and Zhang Y: Involvement of BMPs/Smad signaling pathway in mechanical response in osteoblasts. Cell Physiol Biochem. 26:1093–1102. 2010. View Article : Google Scholar